Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Antibodies > Research Grade Biosimilars

Anti-Human EGFR & HGFR/c-MET Bispecific Reference Antibody (Amivantamab, RUO) (HF004076)

Anti-Human EGFR & HGFR/c-MET Bispecific Reference Antibody (Amivantamab, RUO)
Anti-Human EGFR & HGFR/c-MET Bispecific Reference Antibody (Amivantamab, RUO)
Anti-Human EGFR & HGFR/c-MET Bispecific Reference Antibody (Amivantamab, RUO)
Anti-Human EGFR & HGFR/c-MET Bispecific Reference Antibody (Amivantamab, RUO)
Anti-Human EGFR & HGFR/c-MET Bispecific Reference Antibody (Amivantamab, RUO)
Anti-Human EGFR & HGFR/c-MET Bispecific Reference Antibody (Amivantamab, RUO)
Anti-Human EGFR & HGFR/c-MET Bispecific Reference Antibody (Amivantamab, RUO)
Anti-Human EGFR & HGFR/c-MET Bispecific Reference Antibody (Amivantamab, RUO)
Anti-Human EGFR & HGFR/c-MET Bispecific Reference Antibody (Amivantamab, RUO)
Anti-Human EGFR & HGFR/c-MET Bispecific Reference Antibody (Amivantamab, RUO)
Anti-Human EGFR & HGFR/c-MET Bispecific Reference Antibody (Amivantamab, RUO)
Anti-Human EGFR & HGFR/c-MET Bispecific Reference Antibody (Amivantamab, RUO)
Anti-Human EGFR & HGFR/c-MET Bispecific Reference Antibody (Amivantamab, RUO)
Anti-Human EGFR & HGFR/c-MET Bispecific Reference Antibody (Amivantamab, RUO)
Anti-Human EGFR & HGFR/c-MET Bispecific Reference Antibody (Amivantamab, RUO)
Anti-Human EGFR & HGFR/c-MET Bispecific Reference Antibody (Amivantamab, RUO)
Price(USD):
Spec:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
Number:
Get quote
  • Overview

  • Images

  • References

  • Datasheet

  • SDS

Overview
Catalog No.HF004076
Description
Amivantamab (HF004076) is a research-grade recombinant antibody targeting HER1. Produced in mammalian cells with native-like glycosylation.
Highlights
  • Research Grade — For PK/PD studies, assay development, and ADA research.
  • Native Glycosylation — Mammalian expression ensures native-like patterns.
Species reactivityHuman
ApplicationsELISA, Bioactivity: FACS, Functional assay, Research in vivo
Host speciesHuman
IsotypeIgG1-kappa
Expression system Mammalian cells
Clonality Monoclonal
Tested applications FCM
Target HER1, Receptor tyrosine-protein kinase erbB-1, Proto-oncogene c-ErbB-1, Epidermal growth factor receptor, EGFR, ERBB1, ERBB, Tyrosine-protein kinase Met, Hepatocyte growth factor receptor, Proto-oncogene c-Met, Scatter factor receptor, HGF receptor, SF receptor, HGF/SF receptor, MET
Endotoxin level < 10 EU/mg
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession P00533 & P08581
Form Liquid
Storage buffer 0.01M PBS pH 7.4

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Stability and Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternate NamesBispecific, JNJ-61186372, JNJ-6372, CNTO-4424, JNJ61186372, JNJ-611, 2171511-58-1
BackgroundAmivantamab (JNJ-61186372) is a human EGFR-MET bispecific antibody with immune anticancer activity. Amivantamab inhibits ligand binding, promotes endocytosis and degradation of receptor-antibody complexes, and induces Fc-dependent cytokinesis in macrophages and antibody-dependent cytotoxicity in natural killer cells.
Note For research use only. Not suitable for clinical or therapeutic use.
Images
  • Anti-Human EGFR & HGFR/c-MET Bispecific Reference Antibody (Amivantamab, RUO)

    SDS-PAGE

    SDS-PAGE for Research Grade Amivantamab.

  • Anti-Human EGFR & HGFR/c-MET Bispecific Reference Antibody (Amivantamab, RUO)

    SEC-HPLC

    SEC-HPLC detection for Research Grade Amivantamab.

  • Anti-Human EGFR & HGFR/c-MET Bispecific Reference Antibody (Amivantamab, RUO)

    Bioactivity

    Detects EGFR/ERBB1/HER1 in indirect ELISAs.

  • Anti-Human EGFR & HGFR/c-MET Bispecific Reference Antibody (Amivantamab, RUO)

    Bioactivity

    Detects recombinant human Met (Cat No.: HY196021) in indirect ELISA.

  • Anti-Human EGFR & HGFR/c-MET Bispecific Reference Antibody (Amivantamab, RUO)

    Flow CytoMetry

    Flow-cytometry using APC anti-human EGFR antibody. A431 cells were stained with an irrelevant antibody (Blue Histogram) or an APC anti-human EGFR monoclonal antibody (Catalog: HF004076, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, and cells analysed on a NovoCyte Flow Cytometer.

  • Anti-Human EGFR & HGFR/c-MET Bispecific Reference Antibody (Amivantamab, RUO)

    Flow CytoMetry

    Flow-cytometry using PE anti-human EGFR antibody. A431 cells were stained with an irrelevant antibody (Blue Histogram) or an PE anti-human EGFR monoclonal antibody (Catalog: HF004076, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, and cells analysed on a NovoCyte Flow Cytometer.

  • Anti-Human EGFR & HGFR/c-MET Bispecific Reference Antibody (Amivantamab, RUO)

    Flow CytoMetry

    Flow-cytometry using FITC anti-human EGFR antibody. A431 cells were stained with an irrelevant antibody (Blue Histogram) or an FITC anti-human EGFR monoclonal antibody (Catalog: HF004076, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, and cells analysed on a NovoCyte Flow Cytometer.

  • Anti-Human EGFR & HGFR/c-MET Bispecific Reference Antibody (Amivantamab, RUO)

    Flow CytoMetry

    Flow-cytometry using anti-human EGFR antibody. Untransfected cells (blue Histogram) and Transfected cells (Yellow Histogram) were stained with an anti-human EGFR monoclonal antibody (Catalog: HF004076) at a concentration of 5 µg/ml for 30 mins at RT. After washing, bound antibody was detected using a Goat Anti-Human IgG H&L Polyclonal Antibody, FITC (abinScience: HF690414) and cells analysed on a NovoCyte Flow Cytometer.

References
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: support@abinScience.com

Distributor list